Published in Br Med J on August 09, 1980
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? Adv Urol (2011) 1.05
Bone scintigraphy in benign bone disease. Br Med J (Clin Res Ed) (1984) 0.99
Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone? Skeletal Radiol (2011) 0.95
Radiology of soft tissue sarcoma: discussion paper. J R Soc Med (1982) 0.79
The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol (1967) 2.10
99m Tc-labeled polyphosphate as a skeletal imaging agent. Radiology (1972) 1.98
Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology (1974) 1.69
A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol (1977) 1.58
Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology (1976) 1.44
The pathological basis for skeletal scintigraphy. J Bone Joint Surg Br (1975) 1.17
"Cold" lesions on bone imaging. J Nucl Med (1975) 1.10
Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology (1976) 1.06
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
"Skip" metastases in osteosarcoma. Cancer (1975) 1.05
The role of bone scanning in osteomalacia. J Nucl Med (1978) 0.97
Percutaneous biopsy following positive bone scans. Radiology (1979) 0.95
Rationale for the use of bone scans in selected metastatic and primary bone tumors. Semin Nucl Med (1978) 0.92
Bone scanning: its lack of value in the follow-up of patients with breast cancer. Br J Surg (1979) 0.91
Photoscanning of bone lesions utilizing strontium 85. Radiology (1961) 0.90
Radionuclide skeletal survey in neuroblastoma. Radiology (1979) 0.89
Skeletal metastases in pancreatic carcinoma: study by isotopic bone scanning. Oncology (1976) 0.88
99mTc-diphosphonate concentration in primary breast carcinoma. Radiology (1973) 0.85
Skeletal blood flow: implications for bone-scan interpretation. J Nucl Med (1980) 0.84
Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication. J Nucl Med (1979) 0.82
Bone trauma and related benign disease: assessment by bone scanning. Semin Nucl Med (1976) 0.81
Efficacy of radionuclide scanning in patients with lung cancer. JAMA (1979) 0.81
Utility of bone scanning in detecting occult skeletal metastases from cervical carcinoma. Radiology (1979) 0.81
Paget's disease of bone. Semin Nucl Med (1976) 0.80
Blood flow and tracer uptake in normal and abnormal canine bone: comparisons with Sr-85 microspheres, Kr-81m, and Tc-99m MDP. J Nucl Med (1979) 0.80
Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton. Eur J Nucl Med (1977) 0.79
Concentration of 99mTc diphosphonate in breast tissue. Radiology (1974) 0.78
Radionuclide scanning in patients with advanced malignant melanoma. Clin Nucl Med (1979) 0.78
Augmented radioactivity on bone scans of limbs bearing osteosarcomas. J Nucl Med (1975) 0.78
Extraosseous noncalcified soft-tissue uptake of 99mTc-polyphosphate. J Nucl Med (1974) 0.78
Detection of extraosseous metastases from osteosarcoma with 99mTc-polyphosphate bone scanning. Radiology (1974) 0.78
Liver metastases of oat cell carcinoma of lung detected on 99mTc-diphosphonate bone scan. Clin Nucl Med (1978) 0.78
Detection of bone metastases in urogenital malignancies utilizing 99mTc-labeled phosphate compounds. Urology (1978) 0.77
Letter: Rib abnormality hidden by breast prosthesis. J Nucl Med (1974) 0.77
The abnormal bone scan in intracranial lesions. Radiology (1975) 0.77
Bone scanning-osteogenic sarcoma. Correlation with surgical pathology. Am J Roentgenol Radium Ther Nucl Med (1975) 0.77
Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J Nucl Med (1975) 0.77
Focal decreased skeletal uptake secondary to metastatic disease. Radiology (1976) 0.77
Letter: Incidence of solitary skull and extremity involvement in whole-body scintigrams. J Nucl Med (1976) 0.77
Localization of 99mTc-phosphate compounds in renal tumors. J Nucl Med (1977) 0.77
Bone scan appearance of a Paget's osteosarcoma: failure to concentrate HEDP. J Nucl Med (1977) 0.77
Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report. J Nucl Med (1977) 0.77
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancer. Br J Surg (1978) 0.77
The urinary tract image obtained during 99mTc bone scanning. Clin Radiol (1979) 0.77
Bone marrow metastases without cortical bone involvement in breast cancer patients. Cancer (1979) 0.77
Skeletal scintigraphy. West J Med (1979) 0.76
How ominous is an abnormal scan in bronchogenic carcinoma? JAMA (1979) 0.76
Efficacy of skull imaging in routine bone scanning. J Nucl Med (1974) 0.76
Is there still a place for bone scanning in Ewing's sarcoma? Concise communication. J Nucl Med (1980) 0.76
Use of technetium 99m-labelled sodium pyrophosphate in skeletal scintigraphy. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.76
Serial scintiscanning in breast cancer: the indications and prognostic value. Clin Oncol (1980) 0.76
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Radionuclide migration through the genital tract in infertile women with endometriosis. Hum Reprod (1993) 2.67
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. Gastroenterology (1983) 1.54
Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med (1991) 1.50
Ultrasonography and indium 111 white blood cell scanning for the detection of intraabdominal abscesses. Radiology (1981) 1.48
Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf) (1992) 1.48
Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin's disease. J Nucl Med (1989) 1.47
Evaluation of 111In leukocyte whole body scanning. AJR Am J Roentgenol (1979) 1.41
Letter: Thyrotoxic periodic paralysis in Britain. Br Med J (1975) 1.38
Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med (1982) 1.38
Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys (1995) 1.36
Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid (1998) 1.33
Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol (1991) 1.30
The importance of obtaining thyroid uptake measurement in patients with hyperthyroidism. Nucl Med Commun (1990) 1.28
Fatal retroperitoneal haemorrhage complicating anticoagulant therapy. Postgrad Med J (1979) 1.21
Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev (2001) 1.21
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol (1984) 1.21
Antioxidants: their role in pregnancy and miscarriage. Antioxid Redox Signal (2000) 1.16
Localization of bronchopleural fistula using ventilation scintigraphy. J Nucl Med (1994) 1.15
Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. Arch Surg (1999) 1.14
Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol (1996) 1.11
Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med (1985) 1.11
Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med (1982) 1.10
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Information for patients and staff concerning nuclear medicine. Nucl Med Commun (1992) 1.08
The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer (1981) 1.08
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07
Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg (1990) 1.07
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer (1991) 1.07
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer (1984) 1.05
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer (1988) 1.05
Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? Br Med J (Clin Res Ed) (1986) 1.05
Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension. Br J Clin Pharmacol (1976) 1.04
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun (1987) 1.02
The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) (1991) 1.02
Evaluation of thallium-201 exercise scintigraphy in coronary heart disease. Br Heart J (1979) 1.01
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. Br J Cancer (1991) 0.99
Bone scintigraphy in benign bone disease. Br Med J (Clin Res Ed) (1984) 0.99
Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine. Nucl Med Commun (1999) 0.98
The role of bone scanning in osteomalacia. J Nucl Med (1978) 0.97
The white blood cell scan in orthopedics. Clin Orthop Relat Res (1982) 0.96
Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol (1988) 0.95
2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol (2007) 0.95
Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol (1981) 0.94
Clearance of 99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis (1990) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
Detection of occult abscesses with 111In-labeled leukocytes. AJR Am J Roentgenol (1979) 0.93
Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (2001) 0.92
Uptake of I-131 in the biliary tract: a potential cause of a false-positive result of scintiscan. Clin Nucl Med (1998) 0.92
The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. Br J Cancer (1990) 0.92
Mechanism of 201Tl uptake in tumours. Eur J Nucl Med (1989) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Results of treating 297 thyrotolic patients with 125-I. Lancet (1973) 0.91
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol (1989) 0.91
Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment. Scott Med J (1990) 0.91
The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease. Acta Endocrinol (Copenh) (1989) 0.90
Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment? Postgrad Med J (1987) 0.90
Should a woman taking propylthiouracil breast-feed? Clin Nucl Med (1986) 0.89
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment. Nucl Med Commun (1990) 0.89
Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Cancer (1988) 0.89
The effect of carbimazole therapy on interleukin 2, interleukin 2 receptors and free radicals. Autoimmunity (1990) 0.89
A postal survey of quality assurance in nuclear medicine imaging in the UK during 1988. Nucl Med Commun (1989) 0.88
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. Nucl Med Commun (1987) 0.88
Thyroid carcinoma following iodine-131 therapy. Report of a case and review of the literature. J Clin Endocrinol Metab (1971) 0.88
Radioactive iodine (125I) therapy for thyrotoxicosis. N Engl J Med (1971) 0.88
Dynamic hepatic scintigraphy: the effect of using high administered activity on reproducibility of hepatic perfusion index value. Nucl Med Commun (1991) 0.88
Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol (1992) 0.88
Interleukin-2 receptor and ovarian cancer. Br J Cancer (1993) 0.88
Graves' hyperthyroidism. Spontaneous occurrence after autoimmune hypothyroidism with persistent infiltrative ophthalmopathy. Arch Intern Med (1978) 0.87
Acute medicine teaching in an undergraduate medical curriculum: a blended learning approach. Emerg Med J (2008) 0.87
Papillary carcinoma of the thyroid seven years after I-131 therapy for Graves' disease. Clin Nucl Med (1981) 0.87
Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J Clin Endocrinol Metab (1977) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
Differentiating hepatic abscess from tumor: combined 111In white blood cell and 99mTc liver scans. AJR Am J Roentgenol (1980) 0.87
How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med (2000) 0.87
Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1992) 0.86
Sézary syndrome: a model for migration of T lymphocytes to skin. N Engl J Med (1980) 0.86
Observations on the incidence and mechanism of sinus arrhythmia in man at rest. J Physiol (1971) 0.85
The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension. Transplant Proc (1991) 0.85
Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography? Mol Imaging Biol (2006) 0.85
A fully automated determination of the left ventricular region of interest in nuclear angiocardiography. Cardiovasc Intervent Radiol (1981) 0.84
Role of computed tomography in assessing 'operability' of bronchial carcinoma. Br Med J (Clin Res Ed) (1986) 0.84
Thyroid carcinoma after high-dose external radiotherapy for Hodgkin's disease: report of three cases. Cancer (1980) 0.84
Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J (1992) 0.84
Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: a European multicentre study. Eur J Nucl Med (1991) 0.84
Quantitative 1H-NMR analysis of amniotic fluid. J Pharm Biomed Anal (1993) 0.83
Successful management of Graves' disease in a patient undergoing regular dialysis therapy. Arch Intern Med (1985) 0.83
Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer. Br J Cancer (1992) 0.83
Procedure guideline for thyroid scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med (1996) 0.83
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease. Nucl Med Commun (1989) 0.83
The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells. Immunol Invest (1994) 0.82
Letter: Thyroid cancer after iodine-131 therapy. JAMA (1974) 0.82
Lung scan reports: interpretation by clinicians. Nucl Med Commun (1993) 0.81
Evaluation and medical management of thyroid cancer. Cancer Treat Res (1990) 0.81